NJ’s Amended Medical Marijuana Law: Permits Needed for Alternative Treatment Center

9.30.2019

In this New Jersey Law Journal article, Wilentz attorneys Michael F. Schaff and Lisa Gora discuss the new opportunities available for applicants to operate alternative treatment centers under the Jake Honig Compassionate Use Medical Cannabis Act. The permit process includes three permit types (medical cannabis cultivator, dispensary and manufacturer permits) and three categories of permits (traditional, conditional and microbusiness permits).

This article is part of the New Jersey Law Journal monthly column authored by Michael F. Schaff, Esq. and Lisa Gora, Esq. in collaboration with other cannabis attorneys from Wilentz, Goldman & Spitzer’s Cannabis Law practice group. Mr. Schaff is also co-chair of the NJSBA’s Cannabis Law Committee and Ms. Gora serves as the Committee’s secretary. Both are prolific speakers on the topic of legal cannabis. The column provides timely updates on the impacts of legal cannabis on New Jersey businesses in all industry sectors. 

This article is reprinted here with permission from the September 30 issue of the New Jersey Law Journal. © 2019 ALM Media Properties, LLC. Further duplication without permission is prohibited. All rights reserved.

New Jersey Law Journal

*Cannabis Law Disclaimer: Per federal law, under the Controlled Substances Act, marijuana is categorized as a Schedule I controlled substance.  Possession, use, distribution, and/or sale of cannabis is a Federal crime and is subject to related Federal policy, regardless of any state law that may authorize certain marijuana activity.  Compliance with state marijuana law does not equal compliance with federal law.  Legal advice provided by Wilentz, Goldman & Spitzer, P.A. is designed to counsel clients regarding the validity, scope, meaning, and application of existing and/or proposed cannabis law. Wilentz, Goldman & Spitzer, P.A. will not provide guidance or assistance in circumventing or violating Federal or state cannabis law or policy, and any advice provided by Wilentz, Goldman & Spitzer, P.A. should not be construed as such.